Patent 9506082 was granted and assigned to Nature Technology Corporation on November, 2016 by the United States Patent and Trademark Office.
The present invention relates to recombinant DNA molecules such as plasmids, non-viral vectors, viral vectors and hybrids thereof, and more particularly to vector modifications that improve expression of said DNA molecules in cell lines and organisms.